3,825
+0.66%
Close of 9 Nov 2026, in KRW
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Bukwang Pharm Co
Its shares trade on KRX under the ticker 003000.KS. It has been listed since 5 August 1988. In the fiscal year to 31 December 2025, it reported revenue of ₩200.71bn and net income of ₩12.56bn. At that date it held total assets of ₩476.29bn and shareholders' equity of ₩340.60bn.
Bukwang Pharmaceutical Co., Ltd. engages in the manufacture and sale of pharmaceutical products. The company is headquartered in Seoul, Seoul. The firm operates its business through two segments. The Medicines and Quasi-drugs segment mainly produces and distributes pharmaceutical products including antidiabetic agents, anemic medicines, thyroid parathyroid hormone drugs, antihistamines, epileptic drugs, bronchodilators, stomatitis drugs, anti-malignant tumors, gum nutrition, hepatitis treatments, targeted anticancer agents, and others. The Research and Development segment mainly researches and develops pharmaceutical products.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Pharmaceuticals
- Listed since
- 5 Aug 1988
- Website
- bukwang.co.kr ↗
Leadership
Pay as last reported
- Mr. Wu Hyeon LeeChairman, since 2022
- Mr. Sang Hun KimCo-President
- Mr. Jin Seok SeoCo-President
- Mr. Je Yeong LeeChief Executive Officer, Vice President, Director, since 2024
- Mr. Chang Su JungVice Chairman, since 2013₩653.2m
- Mr. Seong Su KimVice President
- Mr. Gwang Hyeon SungVice President
- Ms. Ji Yeong AhnManaging Director
- Mr. Ji Heon KimManaging Director
- Mr. Yeong Oh WiManaging Director
- Mr. Min Gyu KimAssistant Managing Director
- Mr. Sun Yil GwonAssistant Managing Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Bukwang Pharm Co Ltd has a strong market presence and brand reputation, giving them a competitive advantage in the pharmaceutical industry.
- The company has a diverse portfolio of high-quality products, enabling them to cater to various healthcare needs and target different customer segments.
- Bukwang Pharm Co Ltd has a robust research and development (R&D) department, allowing them to innovate and introduce new pharmaceutical solutions to the market.
Weaknesses
- The company heavily relies on a limited number of key products for a significant portion of their revenue, which exposes them to potential risks and market fluctuations.
- Bukwang Pharm Co Ltd faces challenges in expanding their global presence and penetrating new markets, limiting their growth opportunities outside their domestic market.
Opportunities
- The increasing global demand for healthcare products presents an opportunity for Bukwang Pharm Co Ltd to expand their market reach and increase their revenue.
- The growing aging population and rising healthcare expenditures in many countries provide a favorable environment for the pharmaceutical industry, allowing Bukwang Pharm Co Ltd to capitalize on these trends.
- Strategic partnerships and collaborations with other pharmaceutical companies or research institutions can enhance Bukwang Pharm Co Ltd's capabilities in R&D and accelerate their product development process.
Threats
- Intense competition from both domestic and international pharmaceutical companies poses a threat to Bukwang Pharm Co Ltd's market share and profitability.
- Evolving regulatory and compliance requirements in the pharmaceutical industry can increase operational costs and create challenges for Bukwang Pharm Co Ltd to ensure full compliance.
- Economic downturns or recessions can impact consumer spending on healthcare products, potentially affecting Bukwang Pharm Co Ltd's sales and revenue.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.